EnGeneIC Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

EnGeneIC Ltd (EnGeneIC) is a biopharmaceutical company that develops drugs and other therapeutic molecules. The company develops nanocell platform used as a platform for the creation of custom therapies for cancer. Its cyto-immunotherapy platform releases concentrations of RNA-interference molecules, chemotherapeutic agents, and molecularly targeted drugs into targeted tumor cells. EnGeneIC provides technologies such as targeted drug delivery, EnGeneIC dream vector technology, targeted small interfering RNA delivery and targeted microRNA delivery. The company provides preclinical development and clinical trial services. It develops proprietary EDV nanocell platform for the delivery of chemotherapeutics and functional nucleic acids in cancer. The company operates in Lane Cove West, Australia and New York, the US. EnGeneIC is headquartered in Sydney, New South Wales, Australia.

EnGeneIC Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
EnGeneIC Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EnGeneIC Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
EnGeneIC Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EnGeneIC Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
EnGeneIC Ltd, Medical Devices Deals, 2012 to YTD 2018 9
EnGeneIC Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
EnGeneIC Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
EnGeneIC Raises USD0.2 Million in Venture Financing 11
EnGeneIC Raises USD2.9 Million in Venture Financing 12
EnGeneIC Raises USD10 Million in Series B Financing 13
EnGeneIC Raises USD7 Million Financing 14
Partnerships 15
EnGeneIC Enters into Agreement with Millennium Pharma 15
EnGeneIC Ltd - Key Competitors 16
EnGeneIC Ltd - Key Employees 17
EnGeneIC Ltd - Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List Of Tables


EnGeneIC Ltd, Pharmaceuticals & Healthcare, Key Facts 2
EnGeneIC Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EnGeneIC Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
EnGeneIC Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EnGeneIC Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
EnGeneIC Ltd, Medical Devices Deals, 2012 to YTD 2018 9
EnGeneIC Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
EnGeneIC Raises USD0.2 Million in Venture Financing 11
EnGeneIC Raises USD2.9 Million in Venture Financing 12
EnGeneIC Raises USD10 Million in Series B Financing 13
EnGeneIC Raises USD7 Million Financing 14
EnGeneIC Enters into Agreement with Millennium Pharma 15
EnGeneIC Ltd, Key Competitors 16
EnGeneIC Ltd, Key Employees 17

List Of Figures


EnGeneIC Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
EnGeneIC Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
EnGeneIC Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
EnGeneIC Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
EnGeneIC Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EnGeneIC Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
EnGeneIC Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EnGeneIC Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
EnGeneIC Ltd, Medical Devices Deals, 2012 to YTD 2018 9

EnGeneIC Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

EnGeneIC Ltd (EnGeneIC) is a biopharmaceutical company that develops drugs and other therapeutic molecules. The company develops nanocell platform used as a platform for the creation of custom therapies for

USD 250 View Report

Bespak Europe Ltd - Product Pipeline Analysis, 2019 Update

Bespak Europe Ltd (Bespak), a subsidiary of Consort Medical plc is a medical device company that provides inhalation systems. The company provides products such as inhalation devices, injectables, medical check

USD 750 View Report

Medinol Ltd - Product Pipeline Analysis, 2019 Update

Medinol Ltd (Medinol) is a medical device company that researches, develops and manufactures cardiovascular intervention solutions. The companys products include coronary stent system, bare metal stents, PTCA dilatation catheter, biliary

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available